Why we need to talk about public health - YaleNews
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
In March 2020, as COVID-19 began to disrupt life in communities across the world, Yale epidemiologist Katelyn Jetelina was working at the University of Texas. As the dimensions of the public health crisis grew, she started to hear from more and more members of the campus community who were struggling to find information that was timely and easy to understand. “I just stumbled upon this massive gap,” said Jetelina, now an assistant professor adjunct of epidemiology (chronic diseases) at Yale School of Public Health (YSPH). So, Jetelina decided to meet the moment. She started emailing the university’s faculty, staff, and students with the kinds of information they were looking for, covering everything from the effectiveness of masking to why people should trust vaccines. That’s how her newsletter, Your Local Epidemiologist, was born. Today, Your Local Epidemiologist, a public health newsletter that translates ever-evolving science to the public, reaches more than 500 million readers in more than 92 countries.
This article is an excerpt. To read the full content, visit the original source. YaleNews
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!